tiprankstipranks
Trending News
More News >
Sprint Bioscience AB (SE:SPRINT)
:SPRINT
Sweden Market

Sprint Bioscience AB (SPRINT) Income Statement

Compare
0 Followers

Sprint Bioscience AB Income Statement

Last quarter (Q4 2024), Sprint Bioscience AB's total revenue was kr16.27M, an increase of 49.54% from the same quarter last year. In Q4, Sprint Bioscience AB's net income was kr-4.21M. See Sprint Bioscience AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 65.64Mkr 50.48Mkr 83.00Kkr 35.11Mkr 16.89M
Gross Profit
kr 37.30Mkr 41.79Mkr -60.91Mkr 24.68Mkr 6.43M
Operating Expenses
kr 56.97Mkr 42.63Mkr 47.32Mkr 50.14Mkr 44.10M
Depreciation and Amortization
kr 958.00Kkr 447.00Kkr 618.00Kkr 590.00Kkr 697.00K
EBITDA
kr -17.32Mkr -2.08Mkr -60.00Mkr -24.49Mkr -38.05M
Operating Income
kr -19.67Mkr -845.00Kkr -60.91Mkr -25.47Mkr -37.67M
Other Income/Expenses
kr 1.39Mkr 407.00Kkr 739.00Kkr 383.00Kkr -4.94M
Pretax Income
kr -18.28Mkr -438.00Kkr -60.17Mkr -25.08Mkr -42.79M
Net Income
kr -18.28Mkr -438.00Kkr -60.17Mkr -25.35Mkr -46.23M
Per Share Metrics
Basic EPS
kr -0.26kr -0.01kr -1.43kr -0.73kr -2.23
Diluted EPS
kr -0.26kr -0.01kr -1.43kr -0.73kr -2.23
Weighted Average Shares Outstanding
69.82M 69.81M 42.06M 34.65M 20.70M
Weighted Average Shares Outstanding (Diluted)
69.82M 69.81M 42.06M 34.65M 20.70M
Currency in SEK

Sprint Bioscience AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis